Affiliation:
1. Burzynski Research Institute, Houston, TX,
Abstract
Antineoplastons work as molecular switches, which regulate expression of genes p53 and p21 through demethylation of promoter sequences and acetylation of histones. They also inhibit the uptake of growth-critical amino acids, such as 1- glutamine and 1-leucine in neoplastic cells. Phase II trials indicate efficacy of antineoplastons in low-grade glioma, brain stem glioma, high-grade glioma, adenocarcinoma of the colon, and hepatocellular carcinoma. The best results were observed in children with low-grade glioma, where 74% of patients obtained objective response, and in patients with adenocarcinoma of the colon with liver metastases whose survival rate of more than 5 years is 91% versus 39% in controls on chemotherapy. Gene array studies will explain antineoplaston-induced changes in gene expression.
Subject
Complementary and alternative medicine,Oncology
Reference63 articles.
1. 1. Burzynski SR. Antineoplastons—history of the research (I). Drugs Exptl Clin Res. 1986; 12(suppl 1): 1-9.
2. Potential of Antineoplastons in Diseases of Old Age
3. Investigations on unknown ninhydrin-reacting substances in human blood serum. I. Attempts at identification of three such substances
4. 4. Burzynski SR. Biologically active peptides in human urine: I. Isolation of a group of medium-sized peptides. Physiol Chemo Phys. 1973; 5: 437-447.
5. 5. Burzynski SR, Ungar AL, Lubanski E. Biologically active peptides in human urine: II. Effect on intestinal smooth muscle and heart. Physiol Chem Phys. 1974; 6: 457-468.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献